{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:03:57Z","timestamp":1791234237533,"version":"4.1.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2025KY653"],"award-info":[{"award-number":["2025KY653"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012175","name":"Zhejiang Traditional Chinese Medicine Administration","doi-asserted-by":"publisher","award":["2024ZL277"],"award-info":[{"award-number":["2024ZL277"]}],"id":[{"id":"10.13039\/501100012175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the association between preoperative peripheral venous blood biomarkers and postmenopausal endometrioid endometrial carcinoma (EEC) and to develop a clinical risk prediction model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study was conducted on patients who underwent hysteroscopic examination in the Department of Gynecology, Zhejiang Provincial People\u2019s Hospital, between 2018 and 2024. Clinical data, pathological findings, and peripheral venous blood test results were collected. The t-test and least absolute shrinkage and selection operator (LASSO) regression analysis were performed to identify potential risk factors associated with postmenopausal EEC. Logistic regression analysis was subsequently conducted to determine independent risk factors. A clinical risk prediction model was developed based on these factors, and its discriminative and calibration abilities were assessed. Finally, the model was deployed in an online calculator for clinical application.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After applying inclusion and exclusion criteria, a total of 311 patients were enrolled, including 119 cases of benign endometrial diseases and 192 cases of endometrioid carcinoma. Through t-test analysis, LASSO regression, and logistic regression analysis, five independent risk factors were identified: body mass index (BMI), cancer antigen 125 (CA125), human epididymis protein 4 (HE4), platelet-to-lymphocyte ratio (PLR), and albumin (ALB). A clinical prediction model incorporating these factors was established, yielding an area under the curve (AUC) of 0.936 (95% CI: 0.9081\u20130.9631). At the optimal Youden index, the model demonstrated a specificity of 89.1% and a sensitivity of 90.1%, indicating excellent discriminative and calibration performance. The final model was implemented in an online calculator to facilitate dynamic clinical risk predictions for postmenopausal EEC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>BMI, CA125, HE4, PLR, and ALB were identified as independent risk factors for postmenopausal EEC. The clinical risk prediction model based on preoperative blood biomarkers demonstrated robust predictive performance, supporting its potential application in clinical decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1820474","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:22:25Z","timestamp":1783052545000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of a blood biomarker risk prediction model for postmenopausal endometrioid endometrial cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Hubin","family":"Xu","sequence":"first","affiliation":[{"name":"The Second School of Clinical Medicine, Hangzhou Normal University","place":["Hangzhou, Zhejiang, China"]},{"name":"Center for Reproductive Medicine, Department of Gynecology, Zhejiang Provincial People\u2019s Hospital (Affiliated People\u2019s Hospital, Hangzhou Medical College)","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Second School of Clinical Medicine, Hangzhou Normal University","place":["Hangzhou, Zhejiang, China"]},{"name":"Center for Reproductive Medicine, Department of Gynecology, Zhejiang Provincial People\u2019s Hospital (Affiliated People\u2019s Hospital, Hangzhou Medical College)","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huinan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Department of Gynecology, Zhejiang Provincial People\u2019s Hospital (Affiliated People\u2019s Hospital, Hangzhou Medical College)","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimin","family":"Jiang","sequence":"additional","affiliation":[{"name":"The Second School of Clinical Medicine, Hangzhou Normal University","place":["Hangzhou, Zhejiang, China"]},{"name":"Center for Reproductive Medicine, Department of Gynecology, Zhejiang Provincial People\u2019s Hospital (Affiliated People\u2019s Hospital, Hangzhou Medical College)","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zeng","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Department of Gynecology, Zhejiang Provincial People\u2019s Hospital (Affiliated People\u2019s Hospital, Hangzhou Medical College)","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Department of Gynecology, Zhejiang Provincial People\u2019s Hospital (Affiliated People\u2019s Hospital, Hangzhou Medical College)","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafeng","family":"Shou","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Department of Gynecology, Zhejiang Provincial People\u2019s Hospital (Affiliated People\u2019s Hospital, Hangzhou Medical College)","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqian","family":"Zhao","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Department of Gynecology, Zhejiang Provincial People\u2019s Hospital (Affiliated People\u2019s Hospital, Hangzhou Medical College)","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","article-title":"Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Abu-Rustum","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"B3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/20742835.2010.11441158","article-title":"Endometrial cancer","volume":"366","author":"Amant","year":"2005","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1400893","article-title":"Association of the systemic inflammation and anthropometric measurements with cancer risk: a prospective study in MJ cohort","volume":"14","author":"Bian","year":"2024","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/0284186x.2021.1886323","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in urological tumors: an umbrella review of evidence from systematic reviews and meta-analyses","volume":"60","author":"Mjaess","year":"2021","journal-title":"Acta Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s12885-020-06953-8","article-title":"Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer","volume":"20","author":"Cong","year":"2020","journal-title":"BMC Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13199","article-title":"The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non-small cell lung cancer","volume":"14","author":"Xie","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0360-y","article-title":"Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer","volume":"120","author":"Varkaris","year":"2019","journal-title":"Br J Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.01076","article-title":"Carboplatin and paclitaxel for advanced endometrial cancer: final overall survival and adverse event analysis of a phase III trial (NRG Oncology\/GOG0209)","volume":"38","author":"Miller","year":"2020","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3390\/cancers16051028","article-title":"Recent advances in endometrial cancer prevention, early diagnosis and treatment","volume":"16","author":"Baker-Rand","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2024.11.008","article-title":"Re-evaluating endometrial thickness in symptomatic postmenopausal patients for excluding cancer: systematic review and meta-analysis","volume":"22","author":"Chee","year":"2025","journal-title":"J Am Coll Radiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.07.1146","article-title":"Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a meta-analysis","volume":"96","author":"Chang","year":"2011","journal-title":"Fertil Steril"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/uog.22141","article-title":"Ultrasound diagnosis of endometrial cancer by subjective pattern recognition in women with postmenopausal bleeding: prospective inter-rater agreement and reliability study","volume":"57","author":"Wong","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.3390\/cancers14174343","article-title":"Endometrial cancer detection using a cervical DNA methylation assay (MPap) in women with abnormal uterine bleeding: a multicenter hospital-based validation study","volume":"14","author":"Wen","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34406","article-title":"The WID-EC test for the detection and risk prediction of endometrial cancer","volume":"152","author":"Barrett","year":"2023","journal-title":"Int J Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(23)00466-7","article-title":"Performance of the WID-qEC test versus sonography to detect uterine cancers in women with abnormal uterine bleeding (EPI-SURE): a prospective, consecutive observational cohort study in the UK","volume":"24","author":"Evans","year":"2023","journal-title":"Lancet Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/ogx.0000000000001208","article-title":"DNA methylation testing for endometrial cancer detection in urine, cervicovaginal self-samples and cervical scrapes","volume":"153","author":"Wever","year":"2023","journal-title":"Int J Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-022-06482-8","article-title":"Potential of blood-based biomarker approaches in endometrium and breast cancer: a case-control comparison study","volume":"306","author":"Schuhn","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12672-024-00956-8","article-title":"The predictive value of NLR, PLR and MLR in the differential diagnosis of benign uterine diseases and endometrial Malignant tumors","volume":"15","author":"Qin","year":"2024","journal-title":"Discov Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.3390\/cancers16101935","article-title":"Clinical correlations between serological markers and endometrial cancer","volume":"16","author":"Marin","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.3390\/cancers16213567","article-title":"SIR-EN-new biomarker for identifying patients at risk of endometrial carcinoma in abnormal uterine bleeding at menopause","volume":"16","author":"Ronsini","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv142","article-title":"Anthropometric factors and endometrial cancer risk: a systematic review and dose-response meta-analysis of prospective studies","volume":"26","author":"Aune","year":"2015","journal-title":"Ann Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/cancers14020268","article-title":"Correlation of leptin, proinflammatory cytokines and oxidative stress with tumor size and disease stage of endometrioid (type I) endometrial cancer and review of the underlying mechanisms","volume":"14","author":"Madeddu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.3390\/diagnostics12112834","article-title":"Serum CA125 and HE4 as biomarkers for the detection of endometrial cancer and associated high-risk features","volume":"12","author":"Barr","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000528851","article-title":"The utility of preoperative serum CA125 combined with HE4 to predict lymph node metastasis in endometrial cancer","volume":"88","author":"Prueksaritanond","year":"2023","journal-title":"Gynecol Obstet Invest"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.3390\/cancers14225632","article-title":"Nomograms based on fibrinogen, albumin, neutrophil-lymphocyte ratio, and carbohydrate antigen 125 for predicting endometrial cancer prognosis","volume":"14","author":"Li","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/ncp.10588","article-title":"The use of visceral proteins as nutrition markers: an ASPEN position paper","volume":"36","author":"Evans","year":"2021","journal-title":"Nutr Clin Pract"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1820474\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:22:26Z","timestamp":1783052546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1820474\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":30,"alternative-id":["10.3389\/fendo.2026.1820474"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1820474","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"article-number":"1820474"}}